Collegium Pharmaceutical (COLL) Earnings Date & Reports

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

COLL is expected to report earnings to fall 3.98% to $1.69 per share on July 30

Collegium Pharmaceutical COLL Stock Earnings Reports

Q2'26

Est.

$1.69

Q1'26

Beat

by $0.13

Q4'25

Missed

by $0.10

Q3'25

Beat

by $0.37

Q2'25

Beat

by $0.02

The last earnings report on May 07 showed earnings per share of $1.76, beating the estimate of $1.63. With 150.70K shares outstanding, the current market capitalization sits at 1.09B.

View a ticker or compare two or three

Compare

COLL

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for COLL